Cryo Cell International Inc

CCELNYSECIK 862692HealthcareFiscal year ends Nov 30

Share this page

Link

Story card, 1080 × 1920

Reports and events: 256 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Cryo Cell International Inc, Reports and events
Filed	Form	What it is	Accession number
2022-04-0420:13 ET	S-1	Registration statement	0001193125-22-095092
2022-03-1621:01 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0000950170-22-003951
2022-02-2422:03 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0000950170-22-002003
2022-02-2222:01 ET	10-K	Annual reportPeriod 2021-11-30	0000950170-22-001637
2022-01-2522:01 ET	8-K	3.01 Delisting notice	0000950170-22-000481
2021-12-1522:21 ET	8-K	5.02 Departure or appointment of officers or directors	0001564590-21-060452
2021-10-2521:26 ET	8-K	5.07 Shareholder vote results	0001564590-21-051764
2021-10-1521:01 ET	10-Q	Quarterly reportPeriod 2021-08-31	0001564590-21-050960
2021-10-1520:45 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-21-050957
2021-10-0121:01 ET	DEF 14A	Proxy statementPeriod 2021-10-20	0001193125-21-289831
2021-09-2221:27 ET	8-K	5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits	0001564590-21-048617
2021-08-0421:01 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001564590-21-040910
2021-07-1921:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-21-037044
2021-07-1521:21 ET	10-Q	Quarterly reportPeriod 2021-05-31	0001564590-21-036760
2021-06-3021:00 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001564590-21-035363
2021-04-1620:01 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-21-019173
2021-04-1421:21 ET	10-Q	Quarterly reportPeriod 2021-02-28	0001564590-21-018845
2021-03-0122:21 ET	10-K	Annual reportPeriod 2020-11-30	0001564590-21-009945
2021-02-2522:23 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-21-008966
2020-12-1022:00 ET	8-K	1.01 Entry into a material agreement	0001564590-20-056747
2020-10-1920:10 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-20-046773
2020-10-1521:00 ET	10-Q	Quarterly reportPeriod 2020-08-31	0001564590-20-046540
2020-09-2321:16 ET	8-K	5.07 Shareholder vote results	0001193125-20-252410
2020-09-0821:00 ET	8-K	1.01 Entry into a material agreement; 1.02 Termination of a material agreement	0001193125-20-241086
2020-09-0121:00 ET	DEF 14A	Proxy statementPeriod 2020-09-22	0001193125-20-237275
2020-08-1121:03 ET	8-K	5.08 Item not in the standard list	0001193125-20-216447
2020-07-1321:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-191942
2020-07-1021:15 ET	10-Q	Quarterly reportPeriod 2020-05-31	0001193125-20-191169
2020-06-1121:22 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001193125-20-166773
2020-05-0621:02 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-135019
2020-04-1420:56 ET	10-Q	Quarterly reportPeriod 2020-02-29	0001193125-20-107163
2020-03-0221:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-20-058853
2020-02-2821:50 ET	10-K	Annual reportPeriod 2019-11-30	0001193125-20-056695
2019-11-2722:07 ET	8-K	5.07 Shareholder vote results	0001193125-19-302703
2019-10-2923:38 ET	DEF 14A	Proxy statementPeriod 2019-11-21	0001193125-19-277935
2019-10-1720:01 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-269300
2019-10-1521:05 ET	10-Q	Quarterly reportPeriod 2019-08-31	0001193125-19-267766
2019-10-0901:16 ET	8-K	8.01 Other events	0001193125-19-264637
2019-10-0221:01 ET	8-K	4.01 Change of auditor; 9.01 Financial statements and exhibits	0001193125-19-260827
2019-07-2521:01 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-202614
2019-07-1521:05 ET	10-Q	Quarterly reportPeriod 2019-05-31	0001193125-19-194098
2019-04-1621:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-107922
2019-04-1521:21 ET	10-Q	Quarterly reportPeriod 2019-02-28	0001193125-19-106727
2019-03-0121:46 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-19-061140
2019-02-2822:18 ET	10-K	Annual reportPeriod 2018-11-30	0001193125-19-057945
2018-12-1122:22 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001193125-18-347078
2018-10-2221:15 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-18-304332
2018-10-1521:02 ET	10-Q	Quarterly reportPeriod 2018-08-31	0001193125-18-299303
2018-08-3021:26 ET	8-K/A	9.01 Financial statements and exhibits	0001193125-18-263786
2018-08-1620:16 ET	8-K	1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits	0001193125-18-250669

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:58 ET. Listed shows no prices and gives no investment advice.